2004   Dec, 16 Lupin appoints Indrajit Banerjee as President – Finance and Planning   Dec, 2 Lupin receives IND approvals for anti-TB and anti-psoriasis molecules   Oct, 27 Lupin cranks up the R&D Engine   July, 29 Lupin triples Research spend   June, 9 Lupin and Ind-Swift launch new anti-diarrhoeal drug   April, 28 Lupin FY 2003-04 revenue up 22% at Rs 12.3 bn   April, 22 Lupin receives INDA approval for psoriasis oral treatment   April, 6 Lupin Launches Branded Finished Dosage in the US Sets up Pediatric Sales Force   March, 29 Lupin Enters into Collaboration to Promote Zymar to Pediatricians in the U.S. Lupin Enters into Collaboration to Promote Zymar to Pediatricians in the U.S.   March, 23 Lupin unveils herbal products   March, 22 Lupin Launches Herbal Business   Feb, 28 Lupin enters into an alliance with Baxter for Ceftriaxone   Feb, 24 Lupin receives USFDA approval for Cefixime Suspension   Feb, 13 Lupin receives USFDA approval for Cefixime Tablets   Jan, 20 Lupin Net Profit up 77% at Rs. 400 mn; Net Sales up 10% at Rs. 2629 mn;Debt Equity Ratio improves to 0.85:1   Jan, 8 Lupin appoints new President for Asia Pacific,Latin America   Jan, 2 Lupin launches novel cholesterol-fighter EZEDOC